Kenneth Morris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kenneth Morris has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Harsh S. Shah
Lachman Institute for Pharmaceutical Analysis, Long Island University, 75 Dekalb Avenue, Brooklyn, NY 11201-8423, United States
4 shared publications- Kaushalendra Chaturvedi
Porton Pharma Solutions, Cranbury, USA
4 shared publications Kajal Nahar
Department of Pharmaceutical Sciences, The Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, 11201, United States
3 shared publicationsRusha Sardhara
Lachman Institute for Pharmaceutical Analysis, Long Island University, 75 Dekalb Avenue, Brooklyn, NY 11201-8423, United States
3 shared publicationsSimon Bates
Department of Pharmaceutical Sciences, Arnold and Marie Schwartz College of Pharmacy, Long Island University, 75 Dekalb Ave, Brooklyn, New York 11201, United States
3 shared publications- Harsh S. Shah
J-Star Research Inc., Cranbury, USA
2 shared publications
Latest Publications
- 20 July 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 624, 122037
Bayesian statistical approaches to drug product variability assessment and release
- 20 July 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 624, 122037
Bayesian statistical approaches to drug product variability assessment and release
- 24 September 2020
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 20 (11) , 7328-7340
New Insights on Warfarin Sodium 2-Propanol Solvate Solid-State Changes Using a Multivariate Approach
- 24 September 2020
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 20 (11) , 7328-7340
New Insights on Warfarin Sodium 2-Propanol Solvate Solid-State Changes Using a Multivariate Approach
- 12 June 2020
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 21 (5) , 1-13
Development and Validation of Sample Preparation and an HPLC Analytical Method for Dissolution Testing in Fed-State Simulated Gastric Fluid—Illustrating Its Application for Ibuprofen and Ketoconazole Immediate Release Tablets
Dissolution testing and solubility determinations in different biorelevant media have gained considerable interest in the pharmaceutical industry from early-stage development of new products to forecasting bioequivalence. Among all biorelevant fluids, the preparation of fed-state simulated gastric fluid (FeSSGF) and handling of samples from dissolution/solubility testing in FeSSGF is considered to be relatively challenging. Challenges include maintaining the stability of FeSSGF medium upon sampling, filtration, and mitigating analytical interference of excipients and milk components. To overcome these challenges, standard and uniform working practices are required that are not only helpful in preparation of stable FeSSGF but also serve as a harmonizing guide for the collection of dissolution/solubility samples and their subsequent processing (i.e., handling and assay). The optimization of sample preparation methodology is crucial to reduce method-related variance by ensuring specificity, robustness, and reproducibility with acceptable recovery of the analytes. The sample preparation methodology includes a combination of techniques including filtration, solvent treatment, and centrifugation to remove the interfering media-related components and excipients from the analyte. The analytes of interest were chromatographically separated from the interfering analytes to quantify the drug concentration using the new high-performance liquid chromatography methods with ultraviolet detection. The methods developed allow rapid sample preparation, acceptable specificity, reproducible recoveries (greater than 95% of label claim), and quantification of study drugs (ibuprofen and ketoconazole). The sample preparation technique and method considerations provided here for ibuprofen and ketoconazole can serve as a starting point for solubility and dissolution testing of other small molecules in FeSSGF.
- 12 June 2020
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 21 (5) , 1-13
Development and Validation of Sample Preparation and an HPLC Analytical Method for Dissolution Testing in Fed-State Simulated Gastric Fluid—Illustrating Its Application for Ibuprofen and Ketoconazole Immediate Release Tablets
Dissolution testing and solubility determinations in different biorelevant media have gained considerable interest in the pharmaceutical industry from early-stage development of new products to forecasting bioequivalence. Among all biorelevant fluids, the preparation of fed-state simulated gastric fluid (FeSSGF) and handling of samples from dissolution/solubility testing in FeSSGF is considered to be relatively challenging. Challenges include maintaining the stability of FeSSGF medium upon sampling, filtration, and mitigating analytical interference of excipients and milk components. To overcome these challenges, standard and uniform working practices are required that are not only helpful in preparation of stable FeSSGF but also serve as a harmonizing guide for the collection of dissolution/solubility samples and their subsequent processing (i.e., handling and assay). The optimization of sample preparation methodology is crucial to reduce method-related variance by ensuring specificity, robustness, and reproducibility with acceptable recovery of the analytes. The sample preparation methodology includes a combination of techniques including filtration, solvent treatment, and centrifugation to remove the interfering media-related components and excipients from the analyte. The analytes of interest were chromatographically separated from the interfering analytes to quantify the drug concentration using the new high-performance liquid chromatography methods with ultraviolet detection. The methods developed allow rapid sample preparation, acceptable specificity, reproducible recoveries (greater than 95% of label claim), and quantification of study drugs (ibuprofen and ketoconazole). The sample preparation technique and method considerations provided here for ibuprofen and ketoconazole can serve as a starting point for solubility and dissolution testing of other small molecules in FeSSGF.
- Open Access
- 21 April 2020
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 5 (17) , 9690-9701
Contribution of Crystal Lattice Energy on the Dissolution Behavior of Eutectic Solid Dispersions
In the literature, it is reported that eutectics lead to the enhanced dissolution of a poorly soluble compound. However, the solubility theory suggests that since crystal structures of two components are unchanged that all else being equal, the dissolution rates of a fused mixture (FM) should be the same as a physical mixture (PM). The influence of crystal lattice energy on dissolution profiles was investigated using the PM and FM. Experimental phase diagrams constructed using differential scanning calorimetry data were compared with those theoretically derived. Deviation of the experimental phase diagram curves from the theoretical model indicates the nonideal behavior of both systems (ibuprofen/poly(ethylene glycol)-6000 and acetaminophen/caffeine). Both the binary systems showed an increase in the dissolution rate of the PM and FM. However, the dissolution from the PM was comparable with the FM’s dissolution profile. The theoretical solubility calculations using the modified solubility equation showed that the use of the eutectic temperature instead of the drug’s melting point should give a 3–4-fold increase in drug solubility. However, the correlation between dissolution and solubility calculation showed that the FM did not improve the dissolution when compared with the respective PM’s dissolution profile. The proposed explanation is that the unchanged crystal lattice energy in eutectics still limits the solubility and therefore the dissolution rate.
- 21 April 2020
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 5 (17) , 9690-9701
Open AccessContribution of Crystal Lattice Energy on the Dissolution Behavior of Eutectic Solid Dispersions
In the literature, it is reported that eutectics lead to the enhanced dissolution of a poorly soluble compound. However, the solubility theory suggests that since crystal structures of two components are unchanged that all else being equal, the dissolution rates of a fused mixture (FM) should be the same as a physical mixture (PM). The influence of crystal lattice energy on dissolution profiles was investigated using the PM and FM. Experimental phase diagrams constructed using differential scanning calorimetry data were compared with those theoretically derived. Deviation of the experimental phase diagram curves from the theoretical model indicates the nonideal behavior of both systems (ibuprofen/poly(ethylene glycol)-6000 and acetaminophen/caffeine). Both the binary systems showed an increase in the dissolution rate of the PM and FM. However, the dissolution from the PM was comparable with the FM’s dissolution profile. The theoretical solubility calculations using the modified solubility equation showed that the use of the eutectic temperature instead of the drug’s melting point should give a 3–4-fold increase in drug solubility. However, the correlation between dissolution and solubility calculation showed that the FM did not improve the dissolution when compared with the respective PM’s dissolution profile. The proposed explanation is that the unchanged crystal lattice energy in eutectics still limits the solubility and therefore the dissolution rate.
- Open Access
- 12 March 2019
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 20 (3) , 1-7
Pharmaceutical “New Prior Knowledge”: Twenty-First Century Assurance of Therapeutic Equivalence
Facilitating utility of prior knowledge to accelerate evidence-based new drug development is a focus of several communities of knowledge, such as clinical
- 12 March 2019
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 20 (3) , 1-7
Open AccessPharmaceutical “New Prior Knowledge”: Twenty-First Century Assurance of Therapeutic Equivalence
Facilitating utility of prior knowledge to accelerate evidence-based new drug development is a focus of several communities of knowledge, such as clinical
- 2 January 2019
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 20 (1) , 39
New Insights on Solid-State Changes in the Levothyroxine Sodium Pentahydrate during Dehydration and its Relationship to Chemical Instability
Levothyroxine sodium pentahydrate (LEVO) tablets have been on the US market since the mid-twentieth century and remain the most highly prescribed product. Unfortunately, levothyroxine sodium tablets...
- 2 January 2019
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 20 (1) , 39
New Insights on Solid-State Changes in the Levothyroxine Sodium Pentahydrate during Dehydration and its Relationship to Chemical Instability
Levothyroxine sodium pentahydrate (LEVO) tablets have been on the US market since the mid-twentieth century and remain the most highly prescribed product. Unfortunately, levothyroxine sodium tablets...
- 10 May 2018
- Published by Springer Nature in Pharmaceutical Research
- Vol. 35 (7) , 140
Polymorphic Transformation of Indomethacin during Hot Melt Extrusion Granulation: Process and Dissolution Control
To study and elucidate the effect of the intensity and duration of processing stresses on the possible solid-state changes during a hot melt extrusion granulation process.
- 10 May 2018
- Published by Springer Nature in Pharmaceutical Research
- Vol. 35 (7) , 140
Polymorphic Transformation of Indomethacin during Hot Melt Extrusion Granulation: Process and Dissolution Control
To study and elucidate the effect of the intensity and duration of processing stresses on the possible solid-state changes during a hot melt extrusion granulation process.
- 1 January 2018
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 107 (1) , 2-4
Professor Samuel H. Yalkowsky: Scientist, Mentor, and Molecular Empath
- 1 January 2018
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 107 (1) , 2-4
Professor Samuel H. Yalkowsky: Scientist, Mentor, and Molecular Empath